Researchers have analyzed flotillin levels in samples from individuals with and without Alzheimer’s disease (AD) and determined that serum flotillin levels are negatively associated with brain amyloid deposition. Flotillin could serve as a biomarker to estimate brain amyloid deposition, potentially aiding the early diagnosis of AD.
Browsing: diagnostic assay
Thermo Fisher Scientific (MA, USA) have announced the launch of a new complementary diagnostic immunoassay, the Thermo Scientific QMS Plazomicin Immunoassay, for measuring the concentration of a novel therapeutic antibiotic, plazomicin, used to treat complicated urinary tract infections.
New technology could render point-of-care diagnoses less expensive and much easier to use in remote environments with limited resources.
Researchers have identified a panel of biomarkers in serum samples that could accurately detect the early stages of pancreatic cancer.
An assay developed by PerkinElmer has been utilized for the Fetal Medicine Foundation’s ASPRE study to successfully identify women at risk of preeclampsia.
Researchers have discovered a new biomarker that could detect the risk of cardiovascular disease in asymptomatic patients with lupus.
Beckman Coulter showcase the Beckman Coulter Diagnostic Difference and a range of new products designed to provide comprehensive solutions for laboratory excellence.
PerkinElmer have developed a new immunoassay that can reliably screen for Duchenne muscular dystrophy in new born infants.
Researchers develop a new evaporation-driven technique that uses pillars, which could replace 96-well microplate method for diagnostics.
Sensitivity of currently available tests for transmissible spongiform encephalopathies matched or exceeded by new timed amyloid seeding assay.